tetano
Editor, Senior Moderator
Trends Genet
. 2020 Nov 26;S0168-9525(20)30324-3.
doi: 10.1016/j.tig.2020.11.007. Online ahead of print.
Using Genetics To Dissect SARS-CoV-2 Infection
Patrick Brest[SUP] 1 [/SUP], Baharia Mograbi[SUP] 2 [/SUP], Paul Hofman[SUP] 3 [/SUP], Gerard Milano[SUP] 4 [/SUP]
Affiliations
Abstract
To uncover the key cellular pathways associated with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infectivity, Daniloski and coworkers used CRISPR-based whole-genome screening. Their results could propose new or repositioned drugs for the ongoing fight against COVID-19.
. 2020 Nov 26;S0168-9525(20)30324-3.
doi: 10.1016/j.tig.2020.11.007. Online ahead of print.
Using Genetics To Dissect SARS-CoV-2 Infection
Patrick Brest[SUP] 1 [/SUP], Baharia Mograbi[SUP] 2 [/SUP], Paul Hofman[SUP] 3 [/SUP], Gerard Milano[SUP] 4 [/SUP]
Affiliations
- PMID: 33309104
- PMCID: PMC7689311
- DOI: 10.1016/j.tig.2020.11.007
Abstract
To uncover the key cellular pathways associated with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infectivity, Daniloski and coworkers used CRISPR-based whole-genome screening. Their results could propose new or repositioned drugs for the ongoing fight against COVID-19.